Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicNon-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?The Natural Course of Non-Alcoholic Fatty Liver DiseaseLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Non-invasive diagnosis of liver fibrosis and cirrhosis.Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingHepatic steatosis and Type 2 diabetes: current and future treatment considerations.Biomarkers in nonalcoholic fatty liver diseaseNIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDNoninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials.Controversies in the Diagnosis and Management of NAFLD and NASH.Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseNon-invasive diagnosis of advanced fibrosis and cirrhosis.Non-alcoholic fatty liver disease.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Can NASH be diagnosed, graded, and staged noninvasively?The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practiceA randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease.The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients.Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infectionSystematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.The clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver diseaseAssociation between platelet count as a noninvasive marker and ultrasonographic grading in patients with nonalcoholic Fatty liver disease.
P2860
Q24563068-3B26542D-A276-4273-AB3D-6F5780D5E299Q24563381-2FD3B511-90B8-4248-9FF7-3FA4B27FBDD1Q26744631-1F25C856-AEE0-4301-BF57-A9CCBA9B70FFQ26746947-D8AA8326-8B03-435A-B52E-4D48CC899647Q26777511-6C00D91A-F303-4AF8-9E24-856026132BBCQ26778033-B028321C-A2F0-4494-A0BC-FD53B3B5CB72Q26780252-9C5D3B28-A194-4D01-87BE-5A3907EB7CF9Q26782033-0E165E16-1D97-48EB-B1E4-CE33516915BEQ26828855-A6E01144-CA87-40B6-BB21-C0CBC7852D93Q26852019-7CC06D52-7A80-44BB-A94A-EAB2533D9D47Q27006131-7D8040B7-DEE9-48B1-A99F-B50430566366Q27691399-52C66CEC-1B33-45F7-B2B7-E1213763AA17Q28080541-BC4A25B0-3155-4411-814E-C25B7695FDE4Q28488938-000A0D68-E7F3-4802-A052-20DA259A72AEQ30355082-6E71E4F8-30FE-4204-9F45-1067F5FAB4F4Q30362068-83D2A22A-0FFA-4893-8800-D5994596EDE0Q30366572-CEF146DC-7155-4A5C-882E-7183B902EA3BQ30382172-D0179153-C6F6-4D20-AA12-EDA85457AFAEQ30382278-45641CA1-4BF5-45CC-888A-9CFFFFFC85B9Q30396916-8B8E0789-01AC-4250-85D7-9DA40A900371Q30412296-9F6B5B53-B21F-45BC-AAFF-6EC1206250E7Q30412709-B06058E9-3663-48B5-804A-951A7AEB78F0Q30414504-57F8BB5B-0993-4C20-AD43-379CFF69F984Q30423320-AB3444D8-825E-423B-838F-D4DBA67AC823Q30430392-B4D8C3B2-60D8-4F29-94FD-FDE4203101B5Q30432576-25CC355F-CAD8-4411-B759-48CEB9E0068CQ30435948-7C1B0C8F-BD82-48FE-B945-D83E70B4769AQ30451362-D267DC15-8AA7-4AA6-B910-BE6C4F01FC9DQ30458426-374778E1-1618-4B3A-A8D2-962BB028EA92Q33574413-10319375-65A8-44E4-945F-452210E60C13Q33639969-7E9928C6-FE96-4B82-9E9E-8BD63CC8DB30Q33660027-CFB6AD20-48C0-4E62-9EC6-277E15870613Q33755566-19BF938E-5AE3-427C-B935-0E92C29C0487Q33879548-EA44B49F-BAD9-4936-898E-309C8889604FQ34447506-8AB404A7-0ECF-414F-A466-872C0A40BFC5Q34522981-1927F002-8FDC-4BFE-B8AF-E597A1985003Q34589232-C9C2CC10-6236-4BE7-AEB1-9C35FE241661Q34830398-564ACFA7-CD34-4EDD-976B-7CE1B23813C9Q34923599-1CF7BA86-6F3B-4D47-805A-2CFDC3EA4F0EQ35131597-0C0A9508-B771-4265-AF58-D0AFD154B88D
P2860
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@en
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@nl
type
label
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@en
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@nl
prefLabel
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@en
Simple non-invasive fibrosis s ...... alcoholic fatty liver disease.
@nl
P2093
P356
P1433
P1476
Simple non-invasive fibrosis s ...... -alcoholic fatty liver disease
@en
P2093
Christopher P Day
Elsbeth Henderson
Stephen F Stewart
P304
P356
10.1136/GUT.2010.216077
P407
P577
2010-09-01T00:00:00Z